Prakt. lékáren. 2009; 5(1): 26-28
Pharmaceutical smoking cessation aids
- Klinika nemocí plicních a TBC, Fakultní nemocnice Brno a LF MU
Addiction to tobacco smoking is a wide-spread disease causing increase of morbidity and mortality of milions of people each year. It is
a standard drug addiction with nicotine as a habit-forming substance. While nicotine is denied to the body, withdrawal symptoms occur,
and force the addicted person to light a cigarette.
Tobacco control is a concern of complex character, not only medical, but also social. The article describes current pharmacotherapy
of tobacco dependence which influences the physical dependence by reduction of withdrawal symptoms.
Keywords: smoking, addiction, withdrawal symptoms.
Published: April 1, 2009 Show citation
References
- Králíková E, Byma S, Cífková R, et al. Doporučení pro léčbu závislosti na tabáku. Čas Lék Čes 2005; 144: 327-333.
- Peto R, Lopez AD, Boreham J, Thun M. Mortality from smoking in developed countries 1950-2000. 2nd edition. Oxford University Press.
- www.dokurte.cz
- www.slzt.cz
- www.QuitSmoking.com
- Oncken C, Gonzales D, Nides M, et al. Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation. Arch Intern Med 2006; 166: 1571-1577.
Go to original source... 
Go to PubMed... - Králiková E. Vareniclin. Farmakoterapie 2007; 524(1): 15-20.